Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0ITEEV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Xi3A11 antibody drug conjugate
|
|||||
| Synonyms |
Xi3A11 antibody drug conjugate (Leidos Biomedical Research/NCI)
Click to Show/Hide
|
|||||
| Organization |
Leidos Biomedical Research, Inc.; Leidos Holdings, Inc.; National Cancer Institute
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 2 Indication(s)
Hepatocellular carcinoma [ICD11:2C12]
Investigative
Rhabdomyosarcoma [ICD11:2B55]
Investigative
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Fibroblast growth factor receptor 4 (FGFR4)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.